US3758475A
(en)
|
1971-07-20 |
1973-09-11 |
Sandoz Ag |
Pyrido(2,3-d)pyrimidin 2 ones
|
DE3263567D1
(en)
|
1981-12-14 |
1985-06-20 |
Medea Res Srl |
New compounds with antiinflammatory and antitussive activity, process for their preparation and relative pharmaceutical compositions
|
IT1226048B
(it)
|
1981-12-14 |
1990-12-10 |
Medea Res Srl |
Composti ad attivita'antiinfiammatoria, processo per la loro preparazione e composizioni farmaceutiche relative
|
US4501729A
(en)
|
1982-12-13 |
1985-02-26 |
Research Corporation |
Aerosolized amiloride treatment of retained pulmonary secretions
|
US5981714A
(en)
|
1990-03-05 |
1999-11-09 |
Genzyme Corporation |
Antibodies specific for cystic fibrosis transmembrane conductance regulator and uses therefor
|
JP3167762B2
(ja)
|
1990-11-27 |
2001-05-21 |
武田薬品工業株式会社 |
ピリドピリダジン誘導体およびその用途
|
US5612360A
(en)
|
1992-06-03 |
1997-03-18 |
Eli Lilly And Company |
Angiotensin II antagonists
|
CA2107196A1
(en)
|
1992-09-29 |
1994-03-30 |
Mitsubishi Chemical Corporation |
Carboxamide derivatives
|
GB9317764D0
(en)
|
1993-08-26 |
1993-10-13 |
Pfizer Ltd |
Therapeutic compound
|
RU2136661C1
(ru)
|
1993-10-21 |
1999-09-10 |
Джи Ди Сирл энд Ко. |
Амидинопроизводные, их применение и фармацевтическая композиция
|
DE4405712A1
(de)
|
1994-02-23 |
1995-08-24 |
Basf Ag |
Substituierte Naphthyridine und deren Verwendung
|
NO305987B1
(no)
|
1994-04-11 |
1999-08-30 |
Sankyo Co |
Heterosykliske forbindelser med antidiabetisk aktivitet, deres anvendelse og farmasoeytisk preparat inneholdende disse
|
WO1996010027A1
(en)
|
1994-09-27 |
1996-04-04 |
Janssen Pharmaceutica N.V. |
N-substituted piperidinyl bicyclic benzoate derivatives
|
US5656256A
(en)
|
1994-12-14 |
1997-08-12 |
The University Of North Carolina At Chapel Hill |
Methods of treating lung disease by an aerosol containing benzamil or phenamil
|
US5510379A
(en)
|
1994-12-19 |
1996-04-23 |
Warner-Lambert Company |
Sulfonate ACAT inhibitors
|
US5585115A
(en)
|
1995-01-09 |
1996-12-17 |
Edward H. Mendell Co., Inc. |
Pharmaceutical excipient having improved compressability
|
WO1997036876A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
AU4159297A
(en)
|
1996-08-23 |
1998-03-06 |
Agouron Acquisition Corp. |
Neuropeptide-y ligands
|
JP2002511054A
(ja)
|
1996-12-30 |
2002-04-09 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシル蛋白トランスフェラーゼ阻害薬
|
CO4920215A1
(es)
|
1997-02-14 |
2000-05-29 |
Novartis Ag |
Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
|
US5948814A
(en)
|
1997-02-20 |
1999-09-07 |
The Curators Of The University Of Missouri |
Genistein for the treatment of cystic fibrosis
|
WO1998047868A1
(en)
|
1997-04-18 |
1998-10-29 |
Smithkline Beecham Plc |
Heterocycle-containing urea derivatives as 5ht1a, 5ht1b and 5ht1d receptor antagonists
|
BR9813019A
(pt)
|
1997-10-02 |
2000-09-05 |
Sankyo Co |
Derivados do ácido amidocarboxìlico, agentes para diminuir a glicose do sangue, redutor de lipìdio, para melhorar a resistência à insulina, anti-inflamatório, para imuno regulagem, para inibir a aldose reductase, para inibir a 5-lipoxigenase, para a geração de supressor de peróxido de lipìdio, para ativar a ppar, para minorar a osteoporose, e, composições para a terapia ou prevenção da diabete melito, da hiperlipemia, da obesidade, da tolerância à glicose prejudicada, da resistência à insulina que não a igt, do fìgado gorduroso, de complicações diabéticas, da arterioesclerose, da diabete melito gestacional, da sìndrome do ovário policìstico, da artroesteìte, da artrite reumática, de doenças alérgicas, da asma, do câncer, de doenças auto imunes, da pancreatite, e de cataratas
|
ES2216495T3
(es)
|
1998-02-17 |
2004-10-16 |
G.D. SEARLE & CO. |
Procedimiento para la resolucion enzimatica de lactamas.
|
CA2334298C
(en)
|
1998-06-08 |
2008-01-08 |
Schering Corporation |
Neuropeptide y5 receptor antagonists
|
US6426331B1
(en)
|
1998-07-08 |
2002-07-30 |
Tularik Inc. |
Inhibitors of STAT function
|
AUPP609198A0
(en)
|
1998-09-22 |
1998-10-15 |
Curtin University Of Technology |
Use of non-peptidyl compounds for the treatment of insulin related ailments
|
IL142768A0
(en)
|
1998-12-18 |
2002-03-10 |
Du Pont Pharm Co |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
JP4068305B2
(ja)
|
1999-02-24 |
2008-03-26 |
エフ.ホフマン−ラ ロシュ アーゲー |
3−フェニルピリジン誘導体、およびそのnk−1受容体拮抗薬としての用途
|
PL350427A1
(en)
|
1999-02-24 |
2002-12-16 |
Hoffmann La Roche |
Phenyl− and pyridinyl derivatives as neurokinin 1 antagonists
|
PT1394150E
(pt)
|
1999-02-24 |
2011-02-17 |
Hoffmann La Roche |
Derivados de 4-fenilpiridina e a sua utilização como antagonistas dos receptores de nc-1
|
GB2347739A
(en)
*
|
1999-03-09 |
2000-09-13 |
Pfizer Ltd |
Powder Analysis
|
UA71971C2
(en)
|
1999-06-04 |
2005-01-17 |
Agoron Pharmaceuticals Inc |
Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases
|
JP2003502408A
(ja)
|
1999-06-18 |
2003-01-21 |
バイエル アクチェンゲゼルシャフト |
フェノキシフルオロピリミジン類
|
UA74539C2
(en)
|
1999-12-08 |
2006-01-16 |
Pharmacia Corp |
Crystalline polymorphous forms of celecoxib (variants), a method for the preparation thereof (variants), a pharmaceutical composition (variants)
|
WO2001046165A2
(en)
|
1999-12-16 |
2001-06-28 |
Novartis Ag |
N-heteroaryl-amides and their use as parasiticides
|
KR20020071931A
(ko)
|
2000-01-07 |
2002-09-13 |
트렌스폼 파마수티컬스 인코퍼레이티드 |
다양한 고체-형태들의 고도의 자료 처리 편성, 확인 및분석
|
EP1253923A1
(en)
|
2000-01-28 |
2002-11-06 |
Biogen, Inc. |
Pharmaceutical compositions containing anti-beta 1 integrin compounds and uses
|
US20020065303A1
(en)
|
2000-02-01 |
2002-05-30 |
Bing-Yan Zhu |
Bivalent phenylene inhibitors of factor Xa
|
WO2001081317A1
(en)
|
2000-04-26 |
2001-11-01 |
Gliatech, Inc. |
Chiral imidazoyl intermediates for the synthesis of 2-(4-imidazoyl)-cyclopropyl derivatives
|
WO2001083517A1
(en)
|
2000-05-03 |
2001-11-08 |
Tularik Inc. |
Stat4 and stat6 binding dipeptide derivatives
|
US6499984B1
(en)
|
2000-05-22 |
2002-12-31 |
Warner-Lambert Company |
Continuous production of pharmaceutical granulation
|
CA2379445C
(en)
|
2000-06-01 |
2007-08-21 |
Bristol-Myers Squibb Pharma Company |
Lactams substituted by cyclic succinates as inhibitors of a.beta. protein production
|
TWI259180B
(en)
|
2000-08-08 |
2006-08-01 |
Hoffmann La Roche |
4-Phenyl-pyridine derivatives
|
AU2001291013A1
(en)
|
2000-09-15 |
2002-03-26 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
JP4272338B2
(ja)
|
2000-09-22 |
2009-06-03 |
バイエル アクチェンゲゼルシャフト |
ピリジン誘導体
|
US20020115619A1
(en)
|
2000-10-04 |
2002-08-22 |
Rubenstein Ronald C. |
Compositions and methods for treatment of cystic fibrosis
|
GB2367816A
(en)
|
2000-10-09 |
2002-04-17 |
Bayer Ag |
Urea- and thiourea-containing derivatives of beta-amino acids
|
WO2002034739A1
(en)
|
2000-10-20 |
2002-05-02 |
Merck Patent Gmbh |
Chiral binaphthol derivatives
|
US6884782B2
(en)
|
2000-11-08 |
2005-04-26 |
Amgen Inc. |
STAT modulators
|
MXPA03004832A
(es)
|
2000-12-01 |
2004-05-04 |
Guilford Pharm Inc |
Compuestos y sus usos.
|
GB0102687D0
(en)
|
2001-02-02 |
2001-03-21 |
Pharmacia & Upjohn Spa |
Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
|
US20100074949A1
(en)
|
2008-08-13 |
2010-03-25 |
William Rowe |
Pharmaceutical composition and administration thereof
|
US6531597B2
(en)
|
2001-02-13 |
2003-03-11 |
Hoffmann-La Roche Inc. |
Process for preparation of 2-phenyl acetic acid derivatives
|
CN1533400A
(zh)
|
2001-04-10 |
2004-09-29 |
����˹̩����ҩ��˾ |
用于药物发现的探针、系统和方法
|
BR0209151A
(pt)
|
2001-04-23 |
2004-07-13 |
Hoffmann La Roche |
Uso de antagonistas de receptor nk-1 contra hiperplasia prostática benigna
|
EP1392302A1
(en)
|
2001-05-22 |
2004-03-03 |
Neurogen Corporation |
5-substituted-2-arylpyridines as crf1 modulators
|
US20030083345A1
(en)
|
2001-07-10 |
2003-05-01 |
Torsten Hoffmann |
Method of treatment and/or prevention of brain, spinal or nerve injury
|
US6627646B2
(en)
|
2001-07-17 |
2003-09-30 |
Sepracor Inc. |
Norastemizole polymorphs
|
WO2003007888A2
(en)
|
2001-07-20 |
2003-01-30 |
Adipogenix, Inc. |
Fat accumulation-modulating compounds
|
JP4558314B2
(ja)
|
2001-07-20 |
2010-10-06 |
ベーリンガー インゲルハイム (カナダ) リミテッド |
ウイルスポリメラーゼインヒビター
|
WO2003022852A2
(en)
|
2001-09-11 |
2003-03-20 |
Smithkline Beecham Corporation |
Furo-and thienopyrimidine derivatives as angiogenesis inhibitors
|
PA8557501A1
(es)
|
2001-11-12 |
2003-06-30 |
Pfizer Prod Inc |
Benzamida, heteroarilamida y amidas inversas
|
JP2003155285A
(ja)
|
2001-11-19 |
2003-05-27 |
Toray Ind Inc |
環状含窒素誘導体
|
JP2003221386A
(ja)
|
2001-11-26 |
2003-08-05 |
Takeda Chem Ind Ltd |
二環性誘導体、その製造法およびその用途
|
JP2005518391A
(ja)
|
2001-12-21 |
2005-06-23 |
ノボ ノルディスク アクティーゼルスカブ |
Gk活性化剤としてのアミド誘導体
|
TW200307539A
(en)
|
2002-02-01 |
2003-12-16 |
Bristol Myers Squibb Co |
Cycloalkyl inhibitors of potassium channel function
|
TW200304820A
(en)
|
2002-03-25 |
2003-10-16 |
Avanir Pharmaceuticals |
Use of benzimidazole analogs in the treatment of cell proliferation
|
TW200403058A
(en)
|
2002-04-19 |
2004-03-01 |
Bristol Myers Squibb Co |
Heterocyclo inhibitors of potassium channel function
|
FR2840807B1
(fr)
|
2002-06-12 |
2005-03-11 |
|
Composition cosmetique de soin et/ou de maquillage, structuree par des polymeres silicones et des organogelateurs, sous forme rigide
|
JP2005535710A
(ja)
|
2002-08-09 |
2005-11-24 |
トランス テック ファーマ,インコーポレイテッド |
アリールおよびヘテロアリール化合物ならびに凝固を調節する方法
|
GB0221443D0
(en)
|
2002-09-16 |
2002-10-23 |
Glaxo Group Ltd |
Pyridine derivates
|
JP3546208B2
(ja)
*
|
2002-10-02 |
2004-07-21 |
明治製菓株式会社 |
経口吸収性が改善された抗菌性医薬組成物
|
JP2006505571A
(ja)
|
2002-10-15 |
2006-02-16 |
リゲル ファーマシューテイカルズ、インコーポレイテッド |
置換されたインドール及びhcv阻害剤としてのその使用
|
EP1558576A4
(en)
|
2002-10-30 |
2008-04-16 |
Merck & Co Inc |
PIPERIDINYLCYCLOPENTYLARYLBENZYLAMIDE MODULATORS OF CHEMOKIN RECEPTORACTIVITY
|
EP1565258B1
(en)
|
2002-11-26 |
2011-12-14 |
Universiteit Gent |
Process and apparatus for continuous wet granulation of powder material
|
WO2004054505A2
(en)
|
2002-12-12 |
2004-07-01 |
Pharmacia Corporation |
Method of using aminocyanopyridine compounds as mitogen activated protein kinase-activated protein kinase-2 inhibitors
|
JP4716734B2
(ja)
|
2003-01-06 |
2011-07-06 |
イーライ リリー アンド カンパニー |
グルコキナーゼ活性化物質としての置換されたアリールシクロプロピルアセトアミド
|
NZ542153A
(en)
|
2003-02-10 |
2009-01-31 |
Vertex Pharma |
Processes for the preparation of N-heteroaryl-N-aryl-amines by reacting an N-aryl carbamic acid ester with a halo-heteroaryl and analogous processes
|
US7223788B2
(en)
|
2003-02-14 |
2007-05-29 |
Sanofi-Aventis Deutschland Gmbh |
Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
|
WO2004080972A1
(en)
|
2003-03-12 |
2004-09-23 |
Vertex Pharmaceuticals Incorporated |
Pirazole modulators of atp-binding cassette transporters
|
EP1620420A2
(en)
|
2003-04-30 |
2006-02-01 |
The Institutes for Pharmaceutical Discovery, LLC |
Substituted carboxylic acids
|
WO2004111014A1
(en)
|
2003-06-06 |
2004-12-23 |
Vertex Pharmaceuticals Incorporated |
Pyrimidine derivatives as modulators of atp-binding cassette transporters
|
ATE554766T1
(de)
|
2003-06-27 |
2012-05-15 |
Jackson H M Found Military Med |
Amphiphile pyridinium-verbindungen, herstellungsverfahren und ihre verwendung
|
GB0315111D0
(en)
|
2003-06-27 |
2003-07-30 |
Cancer Rec Tech Ltd |
Substituted 5-membered ring compounds and their use
|
JP2005053902A
(ja)
|
2003-07-18 |
2005-03-03 |
Nippon Nohyaku Co Ltd |
フェニルピリジン類、その中間体及びこれを有効成分とする除草剤
|
JP2007504271A
(ja)
|
2003-09-05 |
2007-03-01 |
ニューロジェン・コーポレーション |
Crf1受容体リガンドである、ヘテロアリール縮合ピリジン類、ピラジン類及びピリミジン類
|
RU2006111093A
(ru)
|
2003-09-06 |
2007-10-27 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Модуляторы атр-связывающих кассетных транспортеров
|
US7534894B2
(en)
|
2003-09-25 |
2009-05-19 |
Wyeth |
Biphenyloxy-acids
|
US20050070718A1
(en)
|
2003-09-30 |
2005-03-31 |
Abbott Gmbh & Co. Kg |
Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
|
ZA200603515B
(en)
|
2003-10-08 |
2007-11-28 |
Vertex Pharma |
Modulators of ATP-binding cassette transporters
|
US20070078120A1
(en)
|
2003-10-21 |
2007-04-05 |
Hitoshi Ban |
Novel piperidine derivative
|
FR2861304B1
(fr)
|
2003-10-23 |
2008-07-18 |
Univ Grenoble 1 |
Modulateurs des canaux cftr
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
CA2545719A1
(en)
|
2003-11-14 |
2005-06-02 |
Vertex Pharmaceuticals Incorporated |
Thiazoles and oxazoles useful as modulators of atp-binding cassette transporters
|
WO2005049034A2
(en)
|
2003-11-19 |
2005-06-02 |
Glaxo Group Limited |
Use of cyclooxygenase-2 selective inhibitors for the treatment of schizophrenic disorders
|
ES2238001B1
(es)
|
2004-01-21 |
2006-11-01 |
Vita Cientifica, S.L. |
Nuevas formas polimorficas de ondansetron, procedimientos para su preparacion, composiciones farmaceuticas que los contienen y su uso como aantiemeticos.
|
ES2791303T3
(es)
|
2004-01-30 |
2020-11-03 |
Vertex Pharma |
Compuesto intermedio de moduladores de transportadores de casete de unión a ATP
|
US7977322B2
(en)
|
2004-08-20 |
2011-07-12 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-binding cassette transporters
|
EP1719765A4
(en)
|
2004-02-19 |
2009-01-07 |
Banyu Pharma Co Ltd |
NEW SULFONAMIDE DERIVATIVE
|
KR101156406B1
(ko)
*
|
2004-03-25 |
2012-06-13 |
아스텔라스세이야쿠 가부시키가이샤 |
솔리페나신 또는 그의 염의 고형 제제용 조성물
|
ES2241496B1
(es)
|
2004-04-15 |
2006-12-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de piridina.
|
WO2005115399A2
(en)
|
2004-04-16 |
2005-12-08 |
Neurogen Corporation |
Imidazopyrazines, imidazopyridines, ans imidazopyrimidines as crf1 receptor ligands
|
US7618978B2
(en)
|
2004-04-22 |
2009-11-17 |
Eli Lilly And Company |
Amides as BACE inhibitors
|
US7585885B2
(en)
|
2004-04-22 |
2009-09-08 |
Eli Lilly And Company |
Pyrrolidine derivatives useful as BACE inhibitors
|
CA2568499A1
(en)
|
2004-06-01 |
2005-12-15 |
Tm Bioscience Corporation |
Method of detecting cystic fibrosis associated mutations
|
TWI428271B
(zh)
|
2004-06-09 |
2014-03-01 |
Smithkline Beecham Corp |
生產藥物之裝置及方法
|
US20140343098A1
(en)
|
2004-06-24 |
2014-11-20 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters
|
US8354427B2
(en)
|
2004-06-24 |
2013-01-15 |
Vertex Pharmaceutical Incorporated |
Modulators of ATP-binding cassette transporters
|
MX341797B
(es)
|
2004-06-24 |
2016-09-02 |
Vertex Pharmaceuticals Incorporated * |
Moduladores de transportadores con casete de union con atp.
|
EP1781253A1
(en)
|
2004-07-01 |
2007-05-09 |
Warner-Lambert Company LLC |
Preparation of pharmaceutical compositions containing nanoparticles
|
AU2005269981A1
(en)
|
2004-07-02 |
2006-02-09 |
Bonck, John A |
Tablet for pulsed delivery
|
CN1993339B
(zh)
|
2004-08-06 |
2013-05-22 |
大塚制药株式会社 |
芳香化合物
|
WO2006037117A1
(en)
|
2004-09-27 |
2006-04-06 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
US8153643B2
(en)
|
2004-10-12 |
2012-04-10 |
Astrazeneca Ab |
Quinazoline derivatives
|
WO2006051394A1
(en)
|
2004-11-15 |
2006-05-18 |
Pfizer Products Inc. |
Azabenzoxazoles for the treatment of cns disorders
|
NZ555502A
(en)
|
2004-12-15 |
2010-12-24 |
Dompe Pha R Ma Spa Res & Mfg |
2-arylpropionic acid derivatives and pharmaceutical compositions containing them
|
JP4790260B2
(ja)
|
2004-12-22 |
2011-10-12 |
出光興産株式会社 |
アントラセン誘導体を用いた有機エレクトロルミネッセンス素子
|
US20080146612A1
(en)
|
2005-01-27 |
2008-06-19 |
Astrazeneca Ab |
Novel Biaromatic Compounds, Inhibitors of the P2X7-Receptor
|
US7888374B2
(en)
|
2005-01-28 |
2011-02-15 |
Abbott Laboratories |
Inhibitors of c-jun N-terminal kinases
|
JPWO2006082952A1
(ja)
|
2005-02-01 |
2008-06-26 |
武田薬品工業株式会社 |
アミド化合物
|
JP5385605B2
(ja)
|
2005-03-11 |
2014-01-08 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Atp結合カセットトランスポーターのモジュレーター
|
US7297700B2
(en)
|
2005-03-24 |
2007-11-20 |
Renovis, Inc. |
Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
|
TWI377206B
(en)
|
2005-04-06 |
2012-11-21 |
Theravance Inc |
Crystalline form of a quinolinone-carboxamide compound
|
EP1710246A1
(en)
|
2005-04-08 |
2006-10-11 |
Schering Aktiengesellschaft |
Sulfoximine-pyrimidine Macrocycles and the salts thereof, a process for making them, and their pharmaceutical use against cancer
|
AU2006236387A1
(en)
|
2005-04-18 |
2006-10-26 |
Neurogen Corporation |
Subtituted heteroaryl CB1 antagonists
|
CN101198333A
(zh)
|
2005-04-19 |
2008-06-11 |
拜尔药品公司 |
芳烷基酸衍生物及其用途
|
CA2604190A1
(en)
|
2005-04-20 |
2006-11-02 |
Merck & Co., Inc. |
Angiotensin ii receptor antagonists
|
AR055054A1
(es)
|
2005-04-22 |
2007-08-01 |
Wyeth Corp |
Cristales formados de clorhidrato de (((2r)-7-(2,6-diclorofenil)-5-fluoro-2,3- dihidro-1-benzofurano-2-il) metil ) amina
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
WO2006127588A2
(en)
|
2005-05-24 |
2006-11-30 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters
|
JP2008545744A
(ja)
|
2005-06-02 |
2008-12-18 |
バイエル・クロツプサイエンス・アクチエンゲゼルシヤフト |
フェニルアルキル置換ヘテロアリール誘導体
|
JP2008543919A
(ja)
|
2005-06-21 |
2008-12-04 |
アステックス・セラピューティクス・リミテッド |
医薬化合物
|
ES2367844T3
(es)
|
2005-08-11 |
2011-11-10 |
Vertex Pharmaceuticals, Inc. |
Moduladores del regulador de la conductancia transmembrana de la fibrosis quística.
|
WO2007021982A2
(en)
|
2005-08-11 |
2007-02-22 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
SI1928886T1
(sl)
|
2005-09-09 |
2011-08-31 |
Glaxosmithkline Llc |
Derivati piridina in njihova uporaba pri zdravljenju psihotiäśnih motenj
|
CN103893145A
(zh)
|
2005-09-23 |
2014-07-02 |
弗·哈夫曼-拉罗切有限公司 |
新型制剂
|
ZA200803701B
(en)
|
2005-10-06 |
2009-08-26 |
Vertex Pharma |
Modulators of ATP-binding Cassette transporters
|
CN101331124B
(zh)
|
2005-10-19 |
2013-08-14 |
格吕伦塔尔有限公司 |
新颖的辣椒素受体配体和它们用于生产药物的用途
|
US20120232059A1
(en)
|
2005-11-08 |
2012-09-13 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette Transporters
|
WO2007054480A1
(en)
|
2005-11-08 |
2007-05-18 |
N.V. Organon |
2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor
|
EP1945632B1
(en)
|
2005-11-08 |
2013-09-18 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic modulators of atp-binding cassette transporters
|
GB0606891D0
(en)
*
|
2006-04-05 |
2006-05-17 |
Council Cent Lab Res Councils |
Raman Analysis Of Pharmaceutical Tablets
|
WO2007067506A2
(en)
|
2005-12-05 |
2007-06-14 |
Smithkline Beecham Corporation |
2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors
|
AU2006331614A1
(en)
|
2005-12-24 |
2007-07-05 |
Vertex Pharmaceuticals Incorporated |
Quinolin- 4 - one derivatives as modulators of ABC transporters
|
CA2635214A1
(en)
|
2005-12-27 |
2007-07-05 |
Vertex Pharmaceuticals Incorporated |
Compounds useful in cftr assays and methods therewith
|
US20110064811A1
(en)
|
2005-12-28 |
2011-03-17 |
Patricia Hurter |
Solid forms of N-[2,4-BIS(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
US7671221B2
(en)
|
2005-12-28 |
2010-03-02 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette transporters
|
AU2006336504C9
(en)
|
2005-12-28 |
2015-05-14 |
Vertex Pharmaceuticals Incorporated |
1-(benzo [D] [1,3] dioxol-5-yl) -N- (phenyl) cyclopropane- carboxamide derivatives and related compounds as modulators of ATP-Binding Cassette transporters for the treatment of Cystic Fibrosis
|
EP1966585A2
(en)
|
2005-12-30 |
2008-09-10 |
Caliper Life Sciences, Inc. |
Integrated dissolution processing and sample transfer system
|
US7645789B2
(en)
|
2006-04-07 |
2010-01-12 |
Vertex Pharmaceuticals Incorporated |
Indole derivatives as CFTR modulators
|
US10022352B2
(en)
|
2006-04-07 |
2018-07-17 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-binding cassette transporters
|
ES2554353T3
(es)
|
2006-04-07 |
2015-12-18 |
Vertex Pharmaceuticals Incorporated |
Moduladores de transportadores del casete de unión a ATP
|
WO2007134279A2
(en)
|
2006-05-12 |
2007-11-22 |
Vertex Pharmaceuticals Incorporated |
Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
JP2009537478A
(ja)
*
|
2006-05-13 |
2009-10-29 |
ノヴォ ノルディスク アクティーゼルスカブ |
レパグリニドとメトホルミンを含む錠剤配合物
|
US8563573B2
(en)
|
2007-11-02 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Azaindole derivatives as CFTR modulators
|
CA2668305C
(en)
|
2006-11-03 |
2017-01-03 |
Vertex Pharmaceuticals Incorporated |
Azaindole derivatives as cftr modulators
|
US7754739B2
(en)
|
2007-05-09 |
2010-07-13 |
Vertex Pharmaceuticals Incorporated |
Modulators of CFTR
|
CA2670105A1
(en)
|
2006-11-27 |
2008-06-05 |
Novartis Ag |
Substituted dihydroimidazoles and their use in the treatment of tumors
|
JP2008183168A
(ja)
*
|
2007-01-30 |
2008-08-14 |
Ebara Corp |
錠剤製造システム
|
US20080260820A1
(en)
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
KR101509829B1
(ko)
|
2007-05-02 |
2015-04-06 |
포톨라 파마슈티컬스, 인코포레이티드 |
혈소판 adp 수용체 억제제로 작용하는 화합물을 이용한 병용요법
|
US8969386B2
(en)
|
2007-05-09 |
2015-03-03 |
Vertex Pharmaceuticals Incorporated |
Modulators of CFTR
|
JP5686596B2
(ja)
|
2007-05-25 |
2015-03-18 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
嚢胞性線維症膜貫通コンダクタンス制御因子の調節因子
|
US20110177999A1
(en)
|
2007-08-09 |
2011-07-21 |
Vertex Pharmaceuticals Incorporated |
Therapeutic Combinations Useful in Treating CFTR Related Diseases
|
JP5389030B2
(ja)
|
2007-08-24 |
2014-01-15 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
(特に)嚢胞性線維症の処置に有用なイソチアゾロピリジノン
|
DE102007042754A1
(de)
|
2007-09-07 |
2009-03-12 |
Bayer Healthcare Ag |
Substituierte 6-Phenylnikotinsäuren und ihre Verwendung
|
US8163772B2
(en)
|
2007-09-14 |
2012-04-24 |
Vertex Pharmaceuticals Incorporated |
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxypheny1]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
NZ583878A
(en)
|
2007-09-14 |
2012-10-26 |
Vertex Pharma |
Modulators of ABC transporter and cystic fibrosis transmembrane conductance regulator (CFTR)
|
FR2921657A1
(fr)
|
2007-09-28 |
2009-04-03 |
Sanofi Aventis Sa |
Derives de nicotinamide, leur preparation et leur application en therapeutique
|
NZ585980A
(en)
|
2007-11-16 |
2012-04-27 |
Vertex Pharma |
Isoquinoline modulators of atp-binding cassette transporters
|
RS55360B1
(sr)
|
2007-12-07 |
2017-03-31 |
Vertex Pharma |
Proces za proizvodnju cikloalkilkarboksiamido-piridin benzoevih kiselina
|
US20100036130A1
(en)
|
2007-12-07 |
2010-02-11 |
Vertex Pharmaceuticals Incorporated |
Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
|
CA2706920C
(en)
|
2007-12-07 |
2018-02-13 |
Vertex Pharmaceuticals Incorporated |
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
|
BRPI0820681A2
(pt)
|
2007-12-07 |
2019-09-24 |
Vertex Pharma |
formulações de ácido 3-(6-(2,2-difluorobenzo[d][1,3]dioxol-5-il)ciclopropanocarboxamido)-3-metilperidin-2-il)benzoico
|
ES2422741T3
(es)
|
2007-12-13 |
2013-09-13 |
Vertex Pharma |
Moduladores del regulador de la conductancia transmembrana de la fibrosis quística
|
WO2009100258A1
(en)
*
|
2008-02-05 |
2009-08-13 |
Hollis-Eden Pharmaceuticals, Inc. |
Pharmaceutical solid state forms
|
JP5523352B2
(ja)
|
2008-02-28 |
2014-06-18 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Cftr修飾因子としてのへテロアリール誘導体
|
NZ588006A
(en)
|
2008-03-31 |
2012-08-31 |
Vertex Pharma |
Pyridine derivatives as CFTR modulators, in particular N-(6-(benzylamino)-5-methylpyridin-2-yl)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamide
|
GB0813709D0
(en)
|
2008-07-26 |
2008-09-03 |
Univ Dundee |
Method and product
|
US20100256184A1
(en)
|
2008-08-13 |
2010-10-07 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical composition and administrations thereof
|
CN102231990B
(zh)
*
|
2008-08-13 |
2013-09-25 |
沃泰克斯药物股份有限公司 |
N-[2,4-双(1,1-二甲基乙基)-5-羟基苯基]-1,4-二氢-4-氧代喹啉-3-甲酰胺的药物组合物和其给药
|
EP2349223A2
(en)
|
2008-09-29 |
2011-08-03 |
Vertex Pharmaceuticals Incorporated |
Dosage units of 3-(6-(1-(2,2-difluorobenzo [d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
|
UA104601C2
(uk)
|
2008-10-23 |
2014-02-25 |
Вертекс Фармасьютікалз, Інкорпорейтед |
Модулятори регулятора трансмембранної провідності при муковісцидозі
|
DK2358680T3
(da)
|
2008-10-23 |
2013-06-24 |
Vertex Pharma |
Faste former af n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluormethyl)phenyl)-3-oxo-5-(trifluormethyl)-1,4-dihydroquinolin-3-carboxamid
|
US20110257223A1
(en)
|
2008-10-23 |
2011-10-20 |
Vertex Pharmaceuticals Incorporated |
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
|
CN102227430A
(zh)
|
2008-10-23 |
2011-10-26 |
沃泰克斯药物股份有限公司 |
囊性纤维化跨膜传导调节因子的调节剂
|
SI2365972T1
(sl)
|
2008-11-06 |
2015-04-30 |
Vertex Pharmaceuticals Incorporated |
Modulatorji prenaĺ alcev z atp-vezavno kaseto
|
UA104876C2
(uk)
|
2008-11-06 |
2014-03-25 |
Вертекс Фармасьютікалз Інкорпорейтед |
Модулятори atф-зв'язувальних касетних транспортерів
|
WO2010078103A1
(en)
|
2008-12-30 |
2010-07-08 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
MX2011009867A
(es)
|
2009-03-20 |
2012-01-12 |
Vertex Pharma |
Proceso para producir moduladores del regulador de conductancia transmembrana de fibrosis quistica.
|
PL2408749T3
(pl)
|
2009-03-20 |
2018-11-30 |
Vertex Pharmaceuticals Incorporated |
Modulatory transbłonowego regulatora przewodnictwa mukowiscydozy
|
WO2010114638A1
(en)
*
|
2009-03-30 |
2010-10-07 |
E. I. Du Pont De Nemours And Company |
Peptide-based tooth whitening reagents
|
DK2427166T3
(da)
|
2009-05-07 |
2014-01-27 |
Gea Pharma Systems Ltd |
Tabletfremstillingsmodul og fremgangsmåde til kontinuerlig fremstilling af tabletter
|
JP5355269B2
(ja)
*
|
2009-07-16 |
2013-11-27 |
大日本住友製薬株式会社 |
顕微ラマン分光法による固体材料中の分散粒子の粒径の測定法
|
RU2543622C2
(ru)
|
2009-09-17 |
2015-03-10 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способ получения азабициклических соединений
|
EP2490687A1
(en)
|
2009-10-22 |
2012-08-29 |
Vertex Pharmaceuticals Incorporated |
Compositions for treatment of cystic fibrosis and other chronic diseases
|
EP2491042A1
(en)
|
2009-10-23 |
2012-08-29 |
Vertex Pharmaceuticals Inc. |
Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide
|
RU2553989C2
(ru)
|
2009-10-23 |
2015-06-20 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способ получения модуляторов регулятора трансмембранной проводимости кистозного фиброза
|
EP2547658A1
(en)
|
2010-03-19 |
2013-01-23 |
Vertex Pharmaceuticals Incorporated |
Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
CA3016080C
(en)
|
2010-03-25 |
2019-08-20 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide
|
US8802868B2
(en)
|
2010-03-25 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
|
BR112012026255A2
(pt)
|
2010-04-07 |
2017-03-14 |
Vertex Pharma |
composições farmacêuticas de ácido 3-(6-(1-(2-,2-difluorbenzo[d][1,3]dioxol-5-il)ciclopropanocarboxamido)-3-metilpiridin-2-il)benzóico e administração das mesmas
|
ES2579965T3
(es)
|
2010-04-07 |
2016-08-17 |
Vertex Pharmaceuticals Incorporated |
Las formas sólidas de 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-il) Ciclopropano carboxamida)-3-metilpiridin-2-il)benzoico
|
JP2013525371A
(ja)
|
2010-04-22 |
2013-06-20 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
シクロアルキルカルボキサミド−インドール化合物の製造方法
|
NZ603042A
(en)
|
2010-04-22 |
2015-02-27 |
Vertex Pharma |
Pharmaceutical compositions comprising cftr modulators and administrations thereof
|
NZ603044A
(en)
|
2010-04-22 |
2015-08-28 |
Vertex Pharma |
Pharmaceutical compositions comprising cftr modulators and administrations thereof
|
CA2796602A1
(en)
|
2010-04-22 |
2011-10-27 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions and administrations thereof
|
AR081920A1
(es)
|
2010-05-20 |
2012-10-31 |
Vertex Pharma |
Procesos de produccion de moduladores del regulador de conductancia transmembrana de fibrosis quistica
|
US20110288122A1
(en)
|
2010-05-20 |
2011-11-24 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical Compositions and Administrations Thereof
|
US8563593B2
(en)
|
2010-06-08 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Formulations of (R)-1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
|
BR112013004443A8
(pt)
|
2010-08-23 |
2018-01-02 |
Vertex Pharma |
composições farmacêuticas de (r)-1-(2,2-difluorbenzo[d] [1,3]dioxol-5-il)-n-(1-(2,3-di-hidróxipropil)-6-flúor-2-(1-hidróxi-2-metilpropan-2-il)-1h-indol-5-il)ciclopropano carboxamida e administração das mesmas
|
CN103153286A
(zh)
|
2010-08-27 |
2013-06-12 |
沃泰克斯药物股份有限公司 |
药物组合物及其施用
|
CN102058889A
(zh)
|
2010-11-05 |
2011-05-18 |
王定豪 |
包含抗凝血类药物的分散片及其应用
|
US8802700B2
(en)
|
2010-12-10 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette transporters
|
WO2012148953A1
(en)
*
|
2011-04-25 |
2012-11-01 |
Stc.Unm |
Solid compositions for pharmaceutical use
|
JP5798400B2
(ja)
*
|
2011-07-26 |
2015-10-21 |
富士電機株式会社 |
医薬品製造制御装置、医薬品製造制御方法、医薬品製造制御プログラム、医薬品製造システム
|
AU2012332225A1
(en)
|
2011-11-02 |
2014-05-15 |
Vertex Pharmaceuticals Incorporated |
Use of (N- [2, 4 -bis (1, 1 -dimethylethyl) - 5 - hydroxyphenyl] - 1, 4 - dihydro - 4 - oxoquinoline - 3 - ca rboxamide) for treating CFTR mediated diseases
|
US20140127901A1
(en)
|
2012-11-08 |
2014-05-08 |
Taiwan Semiconductor Manufacturing Company, Ltd. |
Low-k damage free integration scheme for copper interconnects
|
CA2852991C
(en)
|
2011-11-08 |
2019-12-31 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters
|
RU2644723C2
(ru)
*
|
2012-01-25 |
2018-02-13 |
Вертекс Фармасьютикалз Инкорпорейтед |
Препараты 3-(6-(1-(2, 2-дифторбензо[d][1, 3]диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойной кислоты
|
CN109966264A
(zh)
|
2012-02-27 |
2019-07-05 |
沃泰克斯药物股份有限公司 |
药物组合物及其施用
|
US8674108B2
(en)
|
2012-04-20 |
2014-03-18 |
Vertex Pharmaceuticals Incorporated |
Solid forms of N-[2,4-bis(1,1-dimethylethy)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
EP2659890A1
(en)
*
|
2012-04-30 |
2013-11-06 |
Orphan Synergy Europe - Pharma |
Methods and compositions for the treatment of fibrosis
|
EP2858645A1
(en)
|
2012-06-08 |
2015-04-15 |
Vertex Pharmaceuticals Incorporated |
Pharmaceuticl compositions for the treatment of cftr -mediated disorders
|
CA2878057A1
(en)
|
2012-07-16 |
2014-01-23 |
Rossitza Gueorguieva Alargova |
Pharmaceutical compositions of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof
|
US20140092376A1
(en)
|
2012-10-01 |
2014-04-03 |
Momentive Performance Materials, Inc. |
Container and method for in-line analysis of protein compositions
|
CA2890106C
(en)
*
|
2012-11-02 |
2022-08-02 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions for the treatment of cftr mediated diseases
|
US20140221424A1
(en)
|
2013-01-30 |
2014-08-07 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions for use in the treatment of cystic fibrosis
|
DK3424534T3
(da)
|
2014-04-15 |
2021-07-26 |
Vertex Pharma |
Farmaceutiske sammensætninger til behandling af sygdomme medieret af cystisk fibrosetransmembranledningsregulator
|
MA54649A
(fr)
|
2014-10-06 |
2022-04-27 |
Vertex Pharma |
Modulateurs de régulateur de conductance transmembranaire de la fibrose kystique
|
EP3204358B1
(en)
|
2014-10-07 |
2018-09-19 |
Vertex Pharmaceuticals Incorporated |
Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator
|
WO2016086136A1
(en)
|
2014-11-26 |
2016-06-02 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid cysteamine conjugates of cftr modulators and their use in treating medical disorders
|
MA41031A
(fr)
|
2014-11-26 |
2017-10-03 |
Catabasis Pharmaceuticals Inc |
Conjugués cystéamine-acide gras et leur utilisation comme activateurs de l'autophagie
|
EP3226861A2
(en)
|
2014-12-05 |
2017-10-11 |
Centre National de la Recherche Scientifique (CNRS) |
Compounds for treating cystic fibrosis
|
WO2016123028A1
(en)
|
2015-01-26 |
2016-08-04 |
Rigel Pharmaceuticals, Inc. |
Tetrazolones as carboxylic acid bioisosteres
|
TWI730959B
(zh)
|
2015-05-19 |
2021-06-21 |
英商葛蘭素史克智慧財產發展有限公司 |
作為激酶抑制劑之雜環醯胺
|